Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Beachbody Company ( (BODI) ) is now available.
On January 7, 2026, BODi amended its credit agreement with Tiger Finance, revising key financial covenants to increase minimum liquidity, remove a cap on capital expenditures, reduce required digital subscriptions, and introduce a billings fixed charge coverage ratio that is only tested during defined covenant testing periods. The new structure, under which most covenants are not tested when cash balances exceed a set threshold and the earliest potential interest-rate step-down is deferred to the period ending December 31, 2026, is designed to materially enhance the company’s financial flexibility as it shifts from restructuring to growth initiatives in 2026. Executives said the less restrictive terms reflect improved liquidity and operational performance, highlighted by eight consecutive quarters of positive adjusted EBITDA and a September 30, 2025 cash balance of $34 million exceeding its $25 million debt, positioning BODi to pursue retail expansion and an innovation pipeline while maintaining financial discipline.
The most recent analyst rating on (BODI) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Beachbody Company stock, see the BODI Stock Forecast page.
Spark’s Take on BODI Stock
According to Spark, TipRanks’ AI Analyst, BODI is a Neutral.
Beachbody Company faces significant financial challenges, which heavily impact its overall score. Despite this, the company is showing signs of transformation with positive earnings call results and strategic initiatives. Technical indicators suggest bullish momentum, but valuation concerns persist due to negative profitability metrics.
To see Spark’s full report on BODI stock, click here.
More about Beachbody Company
The Beachbody Company, Inc., now branded as BODi, is a leading fitness and nutrition company focused on structured, step-by-step home fitness and nutrition programs, including well-known offerings such as P90X, INSANITY, 21 Day Fix and the Shakeology supplement line. With a mission to help busy, time‑constrained consumers build sustainable healthy habits, BODi serves a large community of users seeking weight management, improved metabolic health, better sleep, and overall enhanced wellbeing through evidence-based programs and digital subscriptions.
Average Trading Volume: 234,252
Technical Sentiment Signal: Buy
Current Market Cap: $72.87M
For detailed information about BODI stock, go to TipRanks’ Stock Analysis page.